ES2549858T3 - Formas de dosificación resistentes al reflujo gástrico - Google Patents

Formas de dosificación resistentes al reflujo gástrico Download PDF

Info

Publication number
ES2549858T3
ES2549858T3 ES06845613.6T ES06845613T ES2549858T3 ES 2549858 T3 ES2549858 T3 ES 2549858T3 ES 06845613 T ES06845613 T ES 06845613T ES 2549858 T3 ES2549858 T3 ES 2549858T3
Authority
ES
Spain
Prior art keywords
resistant
gastro
gelling agent
dosage forms
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06845613.6T
Other languages
English (en)
Spanish (es)
Inventor
Nachiappan Chidambaram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banner Life Sciences LLC
Original Assignee
Banner Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banner Life Sciences LLC filed Critical Banner Life Sciences LLC
Application granted granted Critical
Publication of ES2549858T3 publication Critical patent/ES2549858T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES06845613.6T 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico Active ES2549858T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/316,830 US20070148248A1 (en) 2005-12-22 2005-12-22 Gastric reflux resistant dosage forms
US316830 2005-12-22
PCT/US2006/048029 WO2007075475A2 (en) 2005-12-22 2006-12-18 Gastric reflux resistant dosage forms

Publications (1)

Publication Number Publication Date
ES2549858T3 true ES2549858T3 (es) 2015-11-02

Family

ID=38007176

Family Applications (3)

Application Number Title Priority Date Filing Date
ES06845613.6T Active ES2549858T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES14150121.3T Active ES2538803T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES15163491.2T Active ES2687807T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES14150121.3T Active ES2538803T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico
ES15163491.2T Active ES2687807T3 (es) 2005-12-22 2006-12-18 Formas de dosificación resistentes al reflujo gástrico

Country Status (6)

Country Link
US (5) US20070148248A1 (https=)
EP (3) EP1973533B1 (https=)
JP (2) JP5627854B2 (https=)
CA (2) CA2798511C (https=)
ES (3) ES2549858T3 (https=)
WO (1) WO2007075475A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE487470T1 (de) * 2002-09-11 2010-11-15 Elan Pharma Int Ltd Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090149433A1 (en) 2007-11-13 2009-06-11 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
WO2013093630A2 (en) 2011-12-22 2013-06-27 Pronova Biopharma Norge As Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
US20130280323A1 (en) * 2012-04-13 2013-10-24 Banner Pharmacaps, Inc. Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
WO2014152097A1 (en) * 2013-03-15 2014-09-25 Banner Pharmacaps Inc. Silk-based capsules
WO2014190324A2 (en) 2013-05-23 2014-11-27 Barlean's Organic Oils, Llc Rotary die system
CA2926335C (en) 2013-10-30 2021-11-23 Banner Life Sciences Llc Enteric soft capsules comprising polyunsaturated fatty acids
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
HUE053962T2 (hu) 2014-09-11 2021-08-30 Gelita Ag Zselatin/pektin részecskék
KR101917334B1 (ko) 2014-10-06 2018-11-09 후지 캡슐 가부시키가이샤 장용성 심리스 소프트 캡슐의 제조 방법
CA2960631C (en) 2014-10-06 2018-06-05 Fuji Capsule Co., Ltd. Method of manufacturing enteric soft capsule
JP2017534630A (ja) 2014-10-31 2017-11-24 バーリーンズ オーガニック オイルズ,エルエルシー ソフトゲルを製造するための方法および装置
ITUB20156821A1 (it) * 2015-12-09 2017-06-09 Altergon Sa CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE
CN105534945B (zh) * 2015-12-29 2020-12-25 仙乐健康科技股份有限公司 一种植物型肠溶软胶囊
US20240408025A1 (en) * 2021-09-13 2024-12-12 Nutrition & Biosciences Usa 1, Llc A film-forming composition comprising pectin
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
CN120282775A (zh) * 2022-12-14 2025-07-08 R·P·谢勒技术有限公司 软凝胶胶囊和制备软凝胶胶囊的方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58172313A (ja) 1982-04-01 1983-10-11 Morishita Jintan Kk 腸溶性軟カプセル
JPS58194810A (ja) * 1982-05-07 1983-11-12 Morishita Jintan Kk コ−テイング軟ミニカプセル
US4719112A (en) * 1982-10-29 1988-01-12 Warner-Lambert Company Foam capsules
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US5146730A (en) * 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5164184A (en) * 1990-10-11 1992-11-17 Kim Young S Process for the preparation of pharmaceutical liquid composition containing Bezoar bovis
JPH05245366A (ja) * 1992-03-04 1993-09-24 Morishita Jintan Kk 内側面が非水溶化された皮膜を有するシームレスカプセルとその製造方法
WO1993019739A1 (en) * 1992-03-30 1993-10-14 Alza Corporation Viscous suspensions of controlled-release drug particles
NZ244796A (en) * 1992-08-18 1995-05-26 Scherer Corp R P Capsule shell of soft gelatin contains a medicament and has a removable tab
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5723552A (en) * 1994-12-21 1998-03-03 Basf Corporation Polyurethane polymer or oligomer having carbamate groups, method for its preparation, and coating composition
US20010003647A1 (en) 1995-06-07 2001-06-14 Ji Sun Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same
KR100219918B1 (ko) * 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물
ES2235380T3 (es) * 1997-12-26 2005-07-01 Warner-Lambert Company Llc Composiciones de gelatina.
MXPA01003197A (es) * 1998-09-28 2004-04-21 Warner Lambert Co Suministro enterico y colonico utilizando capsulas de chpm.
DE69918703T3 (de) * 1998-09-30 2009-04-16 Warner-Lambert Co. Llc Filmbildende zusammensetzungen aus modifizierter stärke
EP1072633A1 (en) 1999-07-22 2001-01-31 Warner-Lambert Company Pullulan film compositions
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
KR100379674B1 (ko) * 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
US6620571B2 (en) * 2000-03-17 2003-09-16 Eastman Kodak Company Method for producing microcapsules having improved wall characteristics
CN1141974C (zh) * 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
EP1186626A1 (en) * 2000-09-05 2002-03-13 Warner-Lambert Company Composition for soluble films with a new hydrolyzed polysaccharide
US6683019B2 (en) * 2001-06-13 2004-01-27 Abb Lummus Global Inc. Catalyst for the metathesis of olefin(s)
DE60238269D1 (de) 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
NO20021592D0 (no) * 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
US20040010069A1 (en) 2002-06-27 2004-01-15 Uniroyal Chemical Company, Inc. Rubber compositions and methods for improving the mooney scorch value and cure rate
DK1545475T3 (da) * 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
EP1426045B1 (de) 2002-12-05 2006-09-27 Symrise GmbH & Co. KG Nahtlose gefüllte Kapseln
US7396874B2 (en) * 2002-12-06 2008-07-08 Hercules Incorporated Cationic or amphoteric copolymers prepared in an inverse emulsion matrix and their use in preparing cellulosic fiber compositions
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
KR100505530B1 (ko) * 2003-09-29 2005-08-03 주식회사 서흥캅셀 어류 젤라틴을 이용한 하드 캅셀 및 그의 제조방법
JP4027352B2 (ja) 2004-09-17 2007-12-26 アンリツ株式会社 光ファイバプローブ装置
DE102007039772A1 (de) 2007-08-22 2009-02-26 Cavis Microcaps Gmbh Mikrokapsel und Verfahren zu deren Herstellung
JP5245366B2 (ja) 2007-11-14 2013-07-24 王子ホールディングス株式会社 偏光板およびその製造方法

Also Published As

Publication number Publication date
EP2716283B1 (en) 2015-04-15
CA2633924C (en) 2013-11-19
JP2009521269A (ja) 2009-06-04
US20140072625A1 (en) 2014-03-13
US8962005B2 (en) 2015-02-24
US20100158958A1 (en) 2010-06-24
JP5627854B2 (ja) 2014-11-19
JP2013209416A (ja) 2013-10-10
EP1973533B1 (en) 2015-07-29
EP2923696B1 (en) 2018-07-11
US10182990B2 (en) 2019-01-22
EP2716283A1 (en) 2014-04-09
ES2687807T3 (es) 2018-10-29
US9192582B2 (en) 2015-11-24
US20150024044A1 (en) 2015-01-22
EP2923696A1 (en) 2015-09-30
CA2798511A1 (en) 2007-07-05
WO2007075475A2 (en) 2007-07-05
US20070148248A1 (en) 2007-06-28
EP1973533A2 (en) 2008-10-01
CA2798511C (en) 2015-04-14
ES2538803T3 (es) 2015-06-24
WO2007075475A3 (en) 2007-12-13
US20170281555A1 (en) 2017-10-05
US9693966B2 (en) 2017-07-04
CA2633924A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
ES2549858T3 (es) Formas de dosificación resistentes al reflujo gástrico
ES2525320T3 (es) Composiciones de calentamiento y sistemas para su descarga
BR122018068450B8 (pt) dispositivo implantável compreendendo gel de alginato
EP4353818A3 (en) Compositions, articles of manufacture and methods related to dosing in cell therapy
EA200801460A1 (ru) Рекомбинантные моновалентные антитела и способы их получения
EA201390630A1 (ru) Композиции микобактериальных антигенов
ATE485064T1 (de) Zusammensetzung und gerät zur knochenwiederherstellung
AR118388A1 (es) Bioconjugados de antígenos-polisacáridos de e. coli, métodos de producción y métodos de utilización de los mismos
CO5570656A2 (es) Liberacin controlada de una sustancia activa a un entorno rico en grasa
BRPI0409357B8 (pt) película de gel termorreversível homogênea, processo para fabricar as películas de gel, cápsulas moles, processo para fabricar as cápsulas moles, e, forma sólida
CO6400196A2 (es) Composiciones de levadura entrelazadas con arcilla y métodos de utilizarlas
DE602005021372D1 (de) Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor
WO2006105173A3 (en) Oral delivery vehicle and material
DE602006014692D1 (de) Film mit reinigungsmittel
Kumari et al. Evaluation of surface roughness and hardness of newer nanoposterior composite resins after immersion in food-simulating liquids
CO6331351A2 (es) Formulaciones que contienen celulosa bacteriana que carecen de un componente de carboximetilcelulosa.
EA201190285A1 (ru) Иммуногенные композиции, имеющие низкую концентрацию хлорида натрия
Romero et al. Ether lipids from archaeas in nano-drug delivery and vaccination
CO6771406A2 (es) Una composición combinada
CN105820642A (zh) 一种吸附甲醛并持续释放负离子的墙面腻子及其制备方法
BRPI0707488B8 (pt) método para a produção de uma composição de epoprostenol, composição farmacêutica e solução estável
BRPI0513702B8 (pt) formas de dosagem e métodos para produção das mesmas
BRPI0818718B8 (pt) processo de preparo de uma composição de vacina compreendendo antígeno e adjuvante na forma de látex inverso de homopolímero do ácido acrílico
MX2019012044A (es) Vacuna para enfermedad intrauterina.
BRPI0414035A (pt) método para formar moldes, núcleo para moldar metal e mistura de material agregado para formar moldes